Article Versions Notes

Duminuco A, Santuccio G, Chiarenza A, Figuera A, Motta G, Caruso AL, Petronaci A, Ippolito M, Cerchione C, Di Raimondo F, et al. Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma. Cancers. 2024; 16(4):826. https://doi.org/10.3390/cancers16040826

Duminuco, Andrea, Gabriella Santuccio, Annalisa Chiarenza, Amalia Figuera, Giovanna Motta, Anastasia Laura Caruso, Alessandro Petronaci, Massimo Ippolito, Claudio Cerchione, Francesco Di Raimondo, and et al. 2024. "Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma" Cancers 16, no. 4: 826. https://doi.org/10.3390/cancers16040826

Duminuco, A., Santuccio, G., Chiarenza, A., Figuera, A., Motta, G., Caruso, A. L., Petronaci, A., Ippolito, M., Cerchione, C., Di Raimondo, F., & Romano, A. (2024). Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma. Cancers, 16(4), 826. https://doi.org/10.3390/cancers16040826